A Mark Glickman

Affiliations

  • Director at Metavia Inc. (MTVA), 2025-07-01
  • Co-Chief Executive Officer at Therapeuticsmd Inc. (TXMD), 2022-12-10
  • Chief Commercial Officer at Esperion Therapeutics Inc. (ESPR), 2020-01-03
  • Chief Commercial Officer at Aralez Pharmaceuticals Inc. (ARLZ), 2018-03-21
  • Chief Commercial Officer at Pozen Inc (POZN), 2015-06-24
  • Evp - Sales And Marketing at Auxilium Pharmaceuticals Inc (AUXL), 2015-01-30
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ARLZ $3.68 25,000 $92,050.00 186,553 2016-05-16 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TXMD $4.92 440 $2,165.46 1,294 2022-12-06 Filing
ARLZ $1.70 5,725 $9,732.50 250,188 2018-03-19 Filing
AUXL $33.16 40,750 $1,351,371.88 27,911 2014-11-20 Filing
AUXL $33.18 7,202 $238,963.08 68,661 2014-11-20 Filing